Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TPM Premix (Poultry) is a non-antibiotic feed additive developed by Avecho Biotechnology using its proprietary Tocopheryl Phosphate Mixture (TPM®) technology. TPM is a chemically synthesized mixture of two phosphorylated forms of Vitamin E: all-rac-α-tocopheryl di-hydrogen phosphate (TP) and all-rac-di-α-tocopheryl hydrogen phosphate (T2P), typically in a 2:1 weight ratio. Designed for oral administration via feed, the premix acts as a nutritional additive and performance enhancer. In broiler studies, it has demonstrated improvements in feed conversion ratios (FCR) by 2-3% under standard conditions and up to 4% under stress conditions like heat. It is currently in preclinical development for poultry applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tocopheryl phosphate mixture.